Please use this identifier to cite or link to this item: https://hdl.handle.net/11000/34541
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPalazón-Bru, Antonio-
dc.contributor.authorMoscardo-Descalzo, Alba-
dc.contributor.authorMorales-Gabriel, Sergio-
dc.contributor.authorFolgado de la Rosa, David Manuel-
dc.contributor.authorMares-García, Emma-
dc.contributor.authorCarbonell Torregrosa, Mª Ángeles-
dc.contributor.authorGil-Guillén, Vicente F-
dc.contributor.otherDepartamentos de la UMH::Medicina Clínicaes_ES
dc.date.accessioned2025-01-15T19:54:02Z-
dc.date.available2025-01-15T19:54:02Z-
dc.date.created2020-12-14-
dc.identifier.citationJ Clin Epidemiol . 2021 Apr:132:46-50es_ES
dc.identifier.issn1878-5921-
dc.identifier.urihttps://hdl.handle.net/11000/34541-
dc.description.abstractObjectives: Many meta-analyses usually omit the number needed to treat, or perform the calculation incorrectly, despite its importance in clinical decision-making. Accordingly, we will explain in an easily understandable way how to perform this procedure to assess the clinical relevance of the intervention. Study Design and Setting: The expressions of the Cochrane Library and the concepts of clinical relevance and evidence-based medicine were applied. Simple cutoff points were also established to facilitate the task of interpreting results. The method was applied to two published meta-analyses to illustrate its application to real cases (treatment nonadherence). Results: In the first example, with a risk in the control group ranging from 0.22 to 0.70, sending mobile phone messages to remind chronic patients to take their medication is clinically relevant with a high degree of evidence. For the second example (single-pill regimen in patients suffering from hypertension and/or dyslipidemia after 6 months), the range of the assumed control risk was between 0.28 and 0.57. Conclusion: The constructed algorithm could be applied to published meta-analyses or incorporated systematically in all meta-analyses with these characteristics.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent5es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectnumber needed to treates_ES
dc.subjectmeta-analysis as topices_ES
dc.subjectclinical trials as topices_ES
dc.subjectdata interpretationes_ES
dc.subjectstatisticales_ES
dc.subjectevidence-based medicinees_ES
dc.subjectmethodses_ES
dc.titleClinical relevance of an intervention assessed by a meta-analysis of randomized clinical trialses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversion10.1016/j.jclinepi.2020.12.010es_ES
Appears in Collections:
Artículos Medicina Clínica


no-thumbnailView/Open:

 Clinical relevance of an intervention assessed by a meta-analysis of.pdf



263,67 kB
Adobe PDF
Share:


Creative Commons ???jsp.display-item.text9???